Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT04779177 · COMPLETED
Trial details
- NCT number
- NCT04779177
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-12
- Primary completion
- 2022-07-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.